A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Frieboes, Hermann B ^a,b,c   Wu, Min ^d   Lowengrub, John ^d   Decuzzi, Paolo ^e   Cristini, Vittorio ^c,f  

^a University of Louisville   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f University of New Mexico   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

ADHESION; ARTICLE; BLOOD VESSEL WALL; CANCER GROWTH; CANCER STAGING; CELL DENSITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLOW RATE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PARTICLE SIZE; PREDICTION; SHEAR RATE; SIMULATION; TRANSPORT KINETICS; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME;

COMPUTER SIMULATION; DIAGNOSTIC IMAGING; MODELS, THEORETICAL; NANOPARTICLES; NEOPLASMS;

EID: 84874526323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056876     Document Type: Article

References (40)

1. Jain RK, (1990) Physiological Barriers to Delivery of Monoclonal Antibodies and Other Macromolecules in Tumors. Cancer Res (Suppl.) 50: 814-819.
2. Jain RK, (2001) Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release 74: 7-25.
3. Jain RK, (2011) Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nature Med 7: 987-989.
4. Allen TM, Cullis PR, (2004) Drug delivery systems: entering the mainstream. Science 303: 1818-22.
5. Ferrari M, (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5: 161-171.
6. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al. (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2: 751-760.
7. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D, (1999) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51: 691-743.
8. Torchilin VP, (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4: 145-160.
9. Matsumura Y, Maeda H, (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1): 6387-6392.
10. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K, (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65: 271-284.
11. Jain RK, Stylianopoulos T, (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7: 653-664.
12. Auerbach R, (1991) Vascular endothelial cell differentiation: organ-specificity and selective affinities as the basis for developing anti-cancer strategies. Int J Radiat Biol 60: 1-10.
13. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W, (2006) Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 58: 1622-1654.
14. Lee SY, Ferrari M, Decuzzi P, (2009) Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20: 495101.
15. Decuzzi P, Ferrari M, (2006) The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27: 5307-5314.
16. Decuzzi P, Pasqualini R, Arap W, Ferrari M, (2009) Intravascular delivery of particulate systems: does geometry really matter? Pharm Res 26: 235-243.
17. van de Ven AL, Wu M, Lowengrub J, McDougall SR, Chaplain MA, et al. (2012) Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv. 2: 11208.
18. van de Ven A, Kim P, Haley O, Fakhoury J, Adriani G, et al. (2012) Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release 158: 148-155.
19. Wu M, Frieboes HB, McDougall S, Chaplain MA, Cristini V, et al. (2013) The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J Theor Biol 320: 131-151.
20. Macklin P, McDougall S, Anderson ARA, Chaplain MAJ, Cristini V, et al. (2009) Multiscale Modeling and Simulation of Vascular Tumour Growth. J Math Biol 58: 765-798.
21. Frieboes HB, Lowengrub JS, Wise SM, Zheng X, Bearer EL, et al. (2007) Computer simulation of glioma growth and morphology. NeuroImage 37: S59-S70.
22. Frieboes HB, Jin F, Chuang YL, Wise SM, Lowengrub JS, et al. (2010) Three-dimensional multispecies tumor growth-II: Tumor invasion and angiogenesis. J Theor Biol 264: 1254-1278.
23. Frieboes HB, Chaplain MA, Thompson AM, Bearer EL, Lowengrub JS, et al. (2011) Physical oncology: a bench-to-bedside quantitative and predictive approach.Cancer Res. 71: 298-302.
24. Boso DP, Lee SY, Ferrari M, Schrefler BA, Decuzzi P, (2011) Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networks. Int J Nanomedicine. 6: 1517-1526.
25. Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, et al. (2003) Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 63: 5838-5843.
26. Smith BR, Cheng Z, De A, Koh AL, Sinclair R, et al. (2008) Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett 8: 2599-2606.
27. Cristini V, Lowengrub J, Nie Q, (2003) Nonlinear simulation of tumor growth. J Math Biol 46: 191-224.
28. Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, et al. (2006) An Integrated Computational/Experimental Model of Tumor Invasion. Cancer Res 66: 1597-1604.
29. Anderson AR, Chaplain MA, (1998) Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 60: 857-899.
30. McDougall SR, Anderson ARA, Chaplain MAJ, (2006) Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications andtherapeutic targeting strategies. J Theor Biol 241: 564-589.
31. Frieboes HB, Edgerton ME, Fruehauf JP, Rose FRAJ, Worrall LK, et al. (2009) Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res 69: 4484-4492.
32. Sinek JP, Sanga S, Zheng X, Frieboes HB, Ferrari M, et al. (2009) Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J Math Biol 58: 485-510.
33. Pham K, Frieboes HB, Cristini V, Lowengrub J, (2011) Predictions of tumour morphological stability and evaluation against experimental observations. J R Soc Interface 8: 16-29.
34. Gompertz B, (1825) On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philos Trans R Soc Lond 115: 513-585.
35. Winsor CP, (1932) The Gompertz curve as a growth curve. Proc Natl Acad Sci 18: 1-8.
36. Laird AK, (1964) Dynamics of tumor growth. Br J Cancer 18: 490-502.
37. Pries AR, Secomb TW, Gaehtgens P, (1998) Structural adaptation and stability of microvascular networks: theory and simulations. Am J Physiol Heart Circ Physiol 275: H349-H360.
38. McDougall SR, Anderson ARA, Chaplain MAJ, Sherratt JA, (2002) Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. Bull Math Biol 64: 673-702.
39. Pries AR, Neuhaus D, Gaehtgens P, (1992) Blood viscosity in tube flow: dependence on diameter and hematocrit. Am J Physiol Heart Circ Physiol 263: H1770-H1778.
40. Caputo KE, Hammer DA, (2005) Effect of microvillus deformability on leukocyte adhesion explored using adhesive dynamics simulations. Biophys J 89: 187-200.